Beckman Coulter Life Sciences has introduced its next-generation Basophil Activation Test (BAT), offering research labs a safer and more efficient tool to study food allergies. Designed to eliminate the risks associated with traditional oral food challenges, this BAT requires only a blood sample, making it a groundbreaking addition to research settings.
The test is developed with dry reagent technology, allowing reagents and allergens to be pre-mixed in a single tube. This innovation simplifies preparation, reduces hands-on time, and improves standardization across workflows—key concerns for lab managers overseeing diverse testing operations.
Benefits of BAT for Lab Managers
- Reduces ethical concerns tied to direct allergen exposure
- Streamlines training with only four pipetting steps
- Decreases variability through standardized reagent formats
- Minimizes equipment needs—no centrifugation or compensation required
- Speeds up workflow with built-in positive and negative controls
- Improves reproducibility, supporting cross-lab consistency
By eliminating complexities and enhancing safety protocols, this assay positions labs to accelerate allergy research with greater confidence and consistency.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit: "Beckman Coulter Life Sciences Launches Safer, Next-Generation Basophil Activation Test to Improve, Expedite Allergy Research"
